Mitchell Gallman

Mitchell Gallman is a Cell and Gene Therapy AD/QC Scientist with over nine years of experience in biological drug design and testing. Currently serving as a Gene Therapy Scientist at the University of Florida, they have previously held various roles at AavantiBio and AGTC, where they developed assays and managed quality control processes. Mitchell has a robust educational background, with a Bachelor of Science in Biotechnology and a minor in Computer Science from the University of Maryland Global Campus, as well as an A.S. in Biology Technician/Biotechnology Laboratory Technician from Santa Fe College. Their passion lies in advancing regenerative medicine to enhance the efficacy, safety, and affordability of new therapies.